Bavarian Nordic to Present at Jefferies 2013 Global Healthcare Conference in London
(Thomson Reuters ONE) -
KVISTGAARD, Denmark - November 15, 2013 - Bavarian Nordic A/S (OMX: BAVA)
announced today that Anders Hedegaard, President & CEO will present at the
Jefferies 2013 Global Healthcare Conference in London on Wednesday, November
20, 2013 at 4:20 p.m. GMT.
The presentation slides will subsequently be available on the company's website:
www.bavarian-nordic.com/investor
Contact
Rolf Sass Sørensen, Vice President Investor Relations & Communications
Phone: +45 33 26 83 83
About Bavarian Nordic
Bavarian Nordic is a vaccine-focused biotechnology company developing and
producing novel vaccines for the treatment and prevention of life-threatening
diseases with a large unmet medical need. The company's pipeline targets cancer
and infectious diseases, and includes ten development programs. In oncology, the
company's lead program is PROSTVAC®, a therapeutic vaccine candidate for
advanced prostate cancer that is the subject of an ongoing pivotal Phase 3
clinical trial and is being developed under a collaboration agreement with the
National Cancer Institute. In clinical Phase 1 and Phase 2 trials, PROSTVAC® has
been tested in nearly 600 patients. In infectious diseases, the company's lead
program is IMVAMUNE®, a non-replicating smallpox vaccine candidate that is being
developed and supplied for emergency use to the U.S. Strategic National
Stockpile under a contract with the U.S. Government. IMVAMUNE® is currently in
clinical Phase 3 development and marketing authorization applications have been
filed in EU and Canada.
Bavarian Nordic's shares are listed on NASDAQ OMX Copenhagen under the symbol
BAVA (Reuters: BAVA.CO, Bloomberg: BAVA.DC). The company has a sponsored Level
1 ADR program listed in the US (OTC) under the symbol BVNRY.
For more information, visit www.bavarian-nordic.com.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Bavarian Nordic A/S via Thomson Reuters ONE
[HUG#1743639]
Unternehmensinformation / Kurzprofil:
Datum: 15.11.2013 - 17:30 Uhr
Sprache: Deutsch
News-ID 317239
Anzahl Zeichen: 2567
contact information:
Town:
Kvistgård
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 129 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Bavarian Nordic to Present at Jefferies 2013 Global Healthcare Conference in London"
steht unter der journalistisch-redaktionellen Verantwortung von
Bavarian Nordic A/S (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
